GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » Policy Acquisition Expense

Maxigen Biotech (TPE:1783) Policy Acquisition Expense


View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Maxigen Biotech Business Description

Traded in Other Exchanges
N/A
Address
No.88, Keji 1st Road, Guishan District, Taoyuan City, TWN, 333
Maxigen Biotech Inc is engaged in collagen purification, research and development, production and sales of implantable medical device, and production, manufacturing, wholesale and retail of cosmetics. The group had two reportable segments: the biomedical products segment and consumer products segment. Biomedical products segment is engaged in the manufacturing and sales of collagen and bone materials. The consumer products segment is involved in the manufacturing and sales of beauty care products. Geographically, it operates in Taiwan, America, Europe, Asia, and other countries, with the majority of the revenue deriving from Taiwan.